ES2165855T3 - Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo. - Google Patents

Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo.

Info

Publication number
ES2165855T3
ES2165855T3 ES93916161T ES93916161T ES2165855T3 ES 2165855 T3 ES2165855 T3 ES 2165855T3 ES 93916161 T ES93916161 T ES 93916161T ES 93916161 T ES93916161 T ES 93916161T ES 2165855 T3 ES2165855 T3 ES 2165855T3
Authority
ES
Spain
Prior art keywords
blood coagulation
active ingredient
storage agent
containing tcf
coagulation containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916161T
Other languages
English (en)
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ES2165855T3 publication Critical patent/ES2165855T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Abstract

UN NORMALIZADOR DE LA COAGULACION DE LA SANGRE QUE CONTIENE TCF-II, UNA GLICOPROTEINA PRODUCIDA POR LOS FIBROBLASTOS HUMANOS, COMO INGREDIENTE ACTIVO. ES EFICAZ PARA EL TRATAMIENTO DE ANOMALIAS EN LA COAGULACION DE LA SANGRE, TALES COMO EL SINDROME DE COAGULACION INTRAVASCULAR DISEMINADA Y LA TROMBOCITOPENIA PROVOCADA POR LA ADMINISTRACION DE CISPLATINA PARA PROMOVER LA PRODUCCION DE LOS FACTORES DE COAGULACION DE LA SANGRE Y AUMENTAR EL NUMERO DE TROMBOCITOS.
ES93916161T 1992-07-16 1993-07-14 Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo. Expired - Lifetime ES2165855T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21222892 1992-07-16
JP11780993 1993-04-21

Publications (1)

Publication Number Publication Date
ES2165855T3 true ES2165855T3 (es) 2002-04-01

Family

ID=26455863

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916161T Expired - Lifetime ES2165855T3 (es) 1992-07-16 1993-07-14 Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo.

Country Status (11)

Country Link
US (1) US5714461A (es)
EP (1) EP0653211B1 (es)
JP (1) JP3634359B2 (es)
KR (1) KR100260964B1 (es)
AT (1) ATE206929T1 (es)
AU (1) AU674871B2 (es)
CA (1) CA2140010C (es)
DE (1) DE69330960T2 (es)
DK (1) DK0653211T3 (es)
ES (1) ES2165855T3 (es)
WO (1) WO1994002165A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0757994T3 (da) * 1994-12-27 2004-01-19 Daiichi Seiyaku Co TCF-mutanter
AU7389496A (en) * 1995-10-05 1997-04-28 Genentech Inc. Methods and compositions for treating vascular stenosis
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
CA2253629A1 (en) 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent for preventing and/or treating cachexia
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
US7741452B2 (en) 2003-12-16 2010-06-22 Toshikazu Nakamura Glycosylation-deficient hepatocyte growth factor
US7262637B2 (en) * 2005-03-22 2007-08-28 Micron Technology, Inc. Output buffer and method having a supply voltage insensitive slew rate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076701A (en) * 1975-07-29 1978-02-28 Immunology Research Foundation, Inc. Tumor complement fraction recovery method and product
US4490549A (en) * 1977-04-19 1984-12-25 The Upjohn Company Enlarged-hetero-ring prostacyclin analogs
JPH0296598A (ja) * 1988-10-03 1990-04-09 Sapporo Breweries Ltd リンフォカイン活性化キラー細胞誘導抑制因子ｌａｋｓｆ，その製造法およびそれを有効成分とする免疫抑制剤
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
DE69131069T2 (de) * 1990-07-13 1999-07-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
ES2110057T3 (es) * 1992-07-16 1998-02-01 Snow Brand Milk Products Co Ltd Composicion medicinal que contiene tcf-ii.
HUT68170A (en) * 1992-12-28 1995-03-21 Snow Brand Milk Products Co Ltd Modified tumor cytotoxic factor /tcf/
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤

Also Published As

Publication number Publication date
JP3634359B2 (ja) 2005-03-30
KR950702433A (ko) 1995-07-29
WO1994002165A1 (en) 1994-02-03
KR100260964B1 (ko) 2000-07-01
EP0653211A4 (en) 1996-06-26
EP0653211A1 (en) 1995-05-17
CA2140010C (en) 2008-04-01
DK0653211T3 (da) 2002-05-06
EP0653211B1 (en) 2001-10-17
AU4583393A (en) 1994-02-14
DE69330960D1 (de) 2001-11-22
CA2140010A1 (en) 1994-02-03
ATE206929T1 (de) 2001-11-15
AU674871B2 (en) 1997-01-16
DE69330960T2 (de) 2002-04-11
US5714461A (en) 1998-02-03

Similar Documents

Publication Publication Date Title
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
ES2089260T3 (es) Composicion topica que contiene lisinato de cetoprofeno.
ES2136618T3 (es) Cicatrizacion de heridas.
ES2158988T3 (es) Composiciones de aerosol.
PE32899A1 (es) Nuevas preparaciones medicamentosas acuosas para la produccion de aerosoles libres de gas propulsor
ES2032390T3 (es) Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).
US8506990B2 (en) Local administration of gallium compositions to treat pain
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
ES2127375T3 (es) Procedimiento de administracion de un farmaco oftalmico.
ES2165855T3 (es) Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo.
Ohkuma Molluscum contagiosum treated with iodine solution and salicylic acid plaster
ES2142388T3 (es) Agente anti-diabetico.
DE3872472D1 (de) Neue heilsalbe, verfahren zu ihrer herstellung, unter verwendung dieser heilsalbe hergestellte applikationsformen sowie deren herstellung.
Reiz et al. EMLA--a eutectic mixture of local anaesthetics for topical anaesthesia
KR910005858A (ko) 지방산 요법
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
ES2106319T3 (es) Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.
EP0147185A3 (en) Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine
ES2138602T3 (es) Agente terapeutico para la amenaza de aborto.
CN1084373A (zh) 美容防感冒手帕
Beitner et al. Prostaglandin E1 treatment of leg ulcers caused by venous or arterial incompetence
DE69531166D1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
Adam et al. Striae and their relation to topical steroid therapy
ES2031930T3 (es) Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 653211

Country of ref document: ES